Who owns Neurogene Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of NGNE from SEC Form 13F filings across 132 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 132 institutions disclosed 24.0M shares of Neurogene Inc. worth $667.2M — about 86.6% of shares outstanding; the largest disclosed holder is JENNISON ASSOCIATES LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
132
13F holders
$667.2M
value, 2026 filers
86.6%
of shares outstanding (24.0M sh)
32
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of NGNE's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | JENNISON ASSOCIATES LLC | 2.2M | $62.0M | 0.0% | 8% | +329.8% |
| 2 | SAMSARA BIOCAPITAL, LLC | 1.9M | $51.9M | 4.9% | 6.7% | +8.7% |
| 3 | Casdin Capital, LLC | 1.6M | $44.1M | 1.9% | 5.7% | +2.6% |
| 4 | Redmile Group, LLC | 1.6M | $43.5M | 3.2% | 5.6% | +10.6% |
| 5 | RTW INVESTMENTS, LP | 1.5M | $42.1M | 0.4% | 5.5% | +11.0% |
| 6 | BlackRock, Inc. | 1.5M | $40.9M | 0.0% | 5.3% | +39.1% |
| 7 | EcoR1 Capital, LLC | 1.3M | $35.4M | 1.6% | 4.6% | 0.0% |
| 8 | BAKER BROS. ADVISORS LP | 991,691 | $27.6M | 0.1% | 3.6% | 0.0% |
| 9 | Trails Edge Capital Partners, LP | 964,885 | $26.8M | 3.9% | 3.5% | +35.0% |
| 10 | T. Rowe Price Investment Management, Inc.NEW | 850,123 | $23.7M | 0.0% | 3.1% | new |
| 11 | MPM BIOIMPACT LLCNEW | 771,839 | $21.5M | 1.6% | 2.8% | new |
| 12 | VANGUARD CAPITAL MANAGEMENT LLC | 711,290 | $19.8M | 0.0% | 2.6% | +32.6% |
| 13 | TORONTO DOMINION BANK | 681,337 | $19.0M | 0.0% | 2.5% | 0.0% |
| 14 | FRANKLIN TEMPLETON INC | 630,859 | $17.4M | 0.0% | 2.3% | +208.8% |
| 15 | STATE STREET CORP | 549,269 | $15.3M | 0.0% | 2% | +144.9% |
| 16 | UBS Group AG | 417,651 | $11.6M | 0.0% | 1.5% | +143.8% |
| 17 | GEODE CAPITAL MANAGEMENT, LLC | 412,768 | $11.5M | 0.0% | 1.5% | +40.8% |
| 18 | FMR LLC | 383,249 | $10.7M | 0.0% | 1.4% | +29.7% |
| 19 | ArrowMark Colorado Holdings LLC | 378,829 | $10.5M | 0.5% | 1.4% | +10.6% |
| 20 | Tyro Capital Management LLCNEW | 304,401 | $8.5M | 1.5% | 1.1% | new |
| 21 | Balyasny Asset Management L.P. | 303,994 | $8.5M | 0.0% | 1.1% | -62.9% |
| 22 | GREAT POINT PARTNERS LLC | 300,000 | $8.3M | 2.0% | 1.1% | -14.8% |
| 23 | Point72 Asset Management, L.P. | 238,967 | $6.6M | 0.0% | 0.9% | +68.4% |
| 24 | MORGAN STANLEY | 221,090 | $6.2M | 0.0% | 0.8% | +15.3% |
| 25 | Driehaus Capital Management LLC | 218,528 | $6.1M | 0.0% | 0.8% | +52.3% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.